For healthcare professionals

SPC Patient Information

Introducing Mydriasert®

Preservative free badge.
  • Mydriasert is an ophthalmic insert containing 0.28mg tropicamide and 5.4mg phenylephrine hydrochloride
  • The two mydriatics work synergistically to provide a wide stable mydriasis2

Mydriasert is indicated to obtain pre-operative mydriasis or for diagnostic purposes where monotherapy is known to be insufficient.1 It is an ophthalmic pellet inserted into the lower conjunctival fornix prior to surgery or diagnostic procedure.1

The lachrymal flow gradually releases the active substances of phenylephrine and tropicamide leading to a wide and stable mydriasis.2

Introduction of Mydriasert can help to improve efficiency in cataract surgery lists.3

Key Features of Mydriasert

  • Provides a wide and stable mydriasis for 60 minutes1,2
  • Known dosage limits risk of overdose1,2
  • Single insertion saves time and is a more efficient use of nurse time3

Biocompatible, preservative free insert for maximum patient comfort; 96% of patients considered their level of comfort to be good.4

Key Features

Advantages over mydriatic drops include:

  • Wide and stable mydriasis1,2
  • Lower exposure to active ingredients1,2
  • Reduced patient preparation time3,4
  • Improved efficiency of cataract service3
  • Superior patient comfort4

How to use

Mydriasert is a hospital only medicine.

The recommended dose is one ophthalmic insert per operated eye to be instilled in the lower fornix a maximum of 2 hours prior to surgery or diagnostic procedure.

DO NOT LEAVE THE OPHTHALMIC INSERT FOR MORE THAN TWO HOURS IN THE LOWER CONJUNCTICAL SAC

Mydriasert is contraindicated in children aged below 12 years. There are no data in children aged 12 to 18 years. Mydriasert is not recommended in these patients.

Do not store above 25°C.

After first opening of the sachet, use immediately. After first use, discard the used insert immediately.

Pack contents

One box of 20 ophthalmic inserts and 20 forceps.

Pricing

NHS Price: £84 for one box of 20 inserts and 20 forceps

PIP code: 367-6509

References

  1. Mydriasert Summary of Product Characteristics.
  2. Gurpreet, K. et al. IOVS June 2017; Vol.58, no.8: 4336.
  3. Shah, A. et al. BMC Ophthalmology (2015) 15:56.
  4. McLauchlan R et al. Eye News 2018;25(2):1-3.
  5. Levet L et al. J Fr Ophtalmol 2004;27(10):1099-1108.
  6. Saenz-de-Viteri M et al. Int J Ophthalmol 2013;6(6):801-4.
  7. Torrón C et al. Biomed Res Int 2013;2013:849349. doi: 10.1155/2013/849349.
  8. Morgado G et al. Eur J Ophthalmol 2010;20(6):989-993.
  9. Mouly, S et al. Basic Clin Pharmacol Toxicol 2006;98:547-554 4.

Page last updated: 9th May 2023

Other Products